about
Erectile dysfunction - an update of current practice and future strategies.Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.PDE5 inhibitors: considerations for preference and long-term adherence.The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction.Avanafil - a further step to tailoring patient needs and expectations.Time of onset of vardenafil orodispersible tablet in a real-life setting - looking beyond randomized clinical trials.
P2860
Q35741898-03119761-7B91-4346-BFBF-A4DE75BCEE3AQ37686844-CC338AB8-1B6D-48C6-88A5-A83A81B0DC2FQ38107001-FAB51BB7-DA69-4B27-98A4-E7569FD944D0Q38122721-E90236A2-A9BA-4003-B20A-2C0D95698FC1Q38692296-4A3274E8-125C-4110-B775-D2C5F022AFB3Q38846047-1474CF0A-ACC8-4CE8-AEA7-3625018620ABQ38994942-5EF9C7CC-AFF6-4FB0-9294-C42A3D88BDA7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vardenafil orodispersible tablet.
@en
Vardenafil orodispersible tablet.
@nl
type
label
Vardenafil orodispersible tablet.
@en
Vardenafil orodispersible tablet.
@nl
prefLabel
Vardenafil orodispersible tablet.
@en
Vardenafil orodispersible tablet.
@nl
P2860
P1433
P1476
Vardenafil orodispersible tablet.
@en
P2093
Mark Sanford
P2860
P356
10.2165/11208270-000000000-00000
P577
2012-01-01T00:00:00Z
P6179
1006394257